There are 2789 resources available
117O - Survival after neoadjuvant therapy with trastuzumab-lapatinib and chemotherapy in patients with HER2-positive early breast cancer: A meta-analysis of randomised trials
Presenter: Valentina Guarneri
Session: Proffered Paper session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
118O - Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: A randomised, phase III trial of the Gruppo Italiano Mammella
Presenter: Lucia Del Mastro
Session: Proffered Paper session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
LBA23 - EPIK-P1: Retrospective chart review study of patients (pts) with <italic>PIK3CA</italic>-related Overgrowth Spectrum (PROS) who have received alpelisib (ALP) as part of a compassionate use programme
Presenter: Guillaume Canaud
Session: Proffered Paper session - Developmental therapeutics
Resources:
Abstract
Slides
Webcast
512O - Interim results from a phase II study of the ATR inhibitor ceralasertib in ARID1A-deficient and ARID1A-intact advanced solid tumor malignancies
Presenter: Rahul Aggarwal
Session: Proffered Paper session - Developmental therapeutics
Resources:
Abstract
Slides
Webcast
513O - A phase I/II multicenter, first-in-human study of DS-7300 (B7-H3 DXd-ADC) in patients (pts) with advanced solid tumors
Presenter: Melissa Johnson
Session: Proffered Paper session - Developmental therapeutics
Resources:
Abstract
Slides
Webcast
514O - An open-label, global, first-in-human study of SKB264 in patients with locally advanced or metastatic solid tumors
Presenter: Jordi Rodon
Session: Proffered Paper session - Developmental therapeutics
Resources:
Abstract
Slides
Webcast
Introduction by the chair
Presenter: Clara Montagut Viladot
Session: Do we need full molecular profile upfront in all CRC patients in daily practice?
Resources:
Slides
Webcast
Yes
Presenter: Sara Lonardi
Session: Do we need full molecular profile upfront in all CRC patients in daily practice?
Resources:
Slides
Webcast
No
Presenter: Rodrigo Dienstmann
Session: Do we need full molecular profile upfront in all CRC patients in daily practice?
Resources:
Slides
Webcast
Polling 2 (led by chair)
Presenter: Clara Montagut Viladot
Session: Do we need full molecular profile upfront in all CRC patients in daily practice?
Resources:
Slides
Webcast